GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ZYME
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Zymeworks Inc stock upgraded to Sell Candidate.
(Updated on Apr 19, 2024)

Sell candidate since Apr 01, 2024 Loss -10.43% PDF

The Zymeworks Inc stock price gained 2.08% on the last trading day (Friday, 19th Apr 2024), rising from $8.67 to $8.85. During the last trading day the stock fluctuated 3.82% from a day low at $8.65 to a day high of $8.98. The price has fallen in 8 of the last 10 days and is down by -8.29% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 151 thousand more shares were traded than the day before. In total, 537 thousand shares were bought and sold for approximately $4.75 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.64 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -15.41% during the next 3 months and, with a 90% probability hold a price between $7.30 and $9.84 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ZYME Signals & Forecast

There are mixed signals in the stock today. The Zymeworks Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.00 and $10.29. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 2.08%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Zymeworks Inc stock

Zymeworks Inc finds support from accumulated volume at $8.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.330 between high and low, or 3.82%. For the last week, the stock has had daily average volatility of 3.61%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ZYME) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Zymeworks Inc to open at $8.83, and during the day (based on 14 day Average True Range), to move between $8.44 and $9.26, which gives a possible trading interval of +/-$0.409 (+/-4.63%) up or down from last closing price. If Zymeworks Inc takes out the full calculated possible swing range there will be an estimated 9.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.67 (2.03%) than the resistance at $9.36 (5.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Zymeworks Inc stock A Buy?

Zymeworks Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.327 Sell Candidate Upgraded

Predicted Opening Price for Zymeworks Inc of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$8.83 ( 0.264%) $8.85

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ZYME

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.16 3.47 %
R2 9.03 2.04 %
R1 8.95 1.16 %
Current price: 8.85
Support S1 8.70 -1.69 %
S2 8.62 -2.57 %
S3 8.50 -3.99 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.81 22.15 %
R2 10.53 18.98 %
R1 9.36 5.76 %
Current price 8.85
Support S1 8.67 -2.03%
S2 0 .
S3 0 .

FAQ

What is the symbol for Zymeworks Inc Stock and on which exchange is it traded?
The symbol for Zymeworks Inc is ZYME and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Zymeworks Inc Stock?
Zymeworks Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Zymeworks Inc Stock?
Zymeworks Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Zymeworks Inc Stock.

What's the current price of Zymeworks Inc Stock?
As of the end of day on the 2024-04-19, the price of an Zymeworks Inc (ZYME) share was $8.85.

What is the 52-week high and low for Zymeworks Inc Stock?
The 52-week high for Zymeworks Inc Stock is $13.14 and the 52-week low is $6.02.

What is the market capitalization of Zymeworks Inc Stock?
As of the 2024-04-19, the market capitalization of Zymeworks Inc is 624.529M.

When is the next earnings date for Zymeworks Inc?
The upcoming earnings date for Zymeworks Inc is May 02, 2024.
Click to get the best stock tips daily for free!

About Zymeworks Inc

Zymeworks Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ... ZYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT